Lloyd Inc. Recalls Thyro-Tab 0.088 mg. Tablets Due to cGMP Deviations
Lloyd Inc. of Iowa is recalling 3.8 million Thyro-Tab 0.088 mg. tablets because they do not meet in-process specification requirements.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II. The source text does not report any illnesses, injuries, or hospitalizations, and the hazard is related to manufacturing deviations rather than a specific high-risk pathogen or structural defect, fitting the criteria for a moderate severity score.
Plain-English summary
Lloyd Inc. of Iowa is recalling 3,826,269 tablets of Thyro-Tab 0.088 mg. The product is packaged in 150,000-tablet bulk drums intended for repackaging and is available by prescription. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
The recall was initiated because the product does not meet in-process specification requirements and involves Current Good Manufacturing Practice (cGMP) deviations. The specific nature of the deviations or the exact specifications not met are not detailed in the source text.
Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution. The affected lots are #HA31411 and #HE17811. Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
- Manufacturer
- Lloyd Inc. of Iowa
- Category
- Drug — Prescription Medication
- Affected units
- 3,826,269
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #HA31411 and #HE17811
Distribution
Part of a larger recall action
This product is one of 12 recalled by Lloyd Inc. of Iowa under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 12 products in this recall →Related recalls
Same manufacturer · Lloyd Inc. of Iowa
See all →- ModerateLloyd Inc. Recalls Levothroid Tablets Due to Quality Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Control Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Levothroid Tablets Due to Stability Failures
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Levothroid Tablets Due to Stability Failures
FDA (Drugs) · 2013-05-29
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14